D Zhao, J Chen, M Chu, X Long… - … Design, Development and …, 2020 - Taylor & Francis
Anaplastic lymphoma kinase (ALK) inhibitors are important treatment options for non-small-
cell lung cancer (NSCLC), associated with ALK gene rearrangement. Patients with ALK …